These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells. Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089 [TBL] [Abstract][Full Text] [Related]
4. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation. Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337 [TBL] [Abstract][Full Text] [Related]
5. BMP9 Induces Cord Blood-Derived Endothelial Progenitor Cell Differentiation and Ischemic Neovascularization via ALK1. Kim J; Kim M; Jeong Y; Lee WB; Park H; Kwon JY; Kim YM; Hwang D; Kwon YG Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2020-31. PubMed ID: 26229139 [TBL] [Abstract][Full Text] [Related]
6. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting. van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445 [TBL] [Abstract][Full Text] [Related]
7. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer. Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893 [TBL] [Abstract][Full Text] [Related]
8. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. Cunha SI; Pardali E; Thorikay M; Anderberg C; Hawinkels L; Goumans MJ; Seehra J; Heldin CH; ten Dijke P; Pietras K J Exp Med; 2010 Jan; 207(1):85-100. PubMed ID: 20065063 [TBL] [Abstract][Full Text] [Related]
9. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059 [TBL] [Abstract][Full Text] [Related]
10. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice. Kim KL; Suh W Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845 [TBL] [Abstract][Full Text] [Related]
11. miRNA involvement in angiogenesis in age-related macular degeneration. Wang L; Lee AY; Wigg JP; Peshavariya H; Liu P; Zhang H J Physiol Biochem; 2016 Dec; 72(4):583-592. PubMed ID: 27349759 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation. Yan Z; Shi H; Zhu R; Li L; Qin B; Kang L; Chen H; Guan H Mol Vis; 2018; 24():83-93. PubMed ID: 29422766 [TBL] [Abstract][Full Text] [Related]
15. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Larrivée B; Prahst C; Gordon E; del Toro R; Mathivet T; Duarte A; Simons M; Eichmann A Dev Cell; 2012 Mar; 22(3):489-500. PubMed ID: 22421041 [TBL] [Abstract][Full Text] [Related]
16. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization. Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924 [TBL] [Abstract][Full Text] [Related]
17. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602 [TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein‑9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1/2 pathways in vitro. Li H; Zhao D; Wang S; Ding J; Zhao L Mol Med Rep; 2016 Nov; 14(5):4545-4550. PubMed ID: 27748860 [TBL] [Abstract][Full Text] [Related]
19. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II. Kim JH; Peacock MR; George SC; Hughes CC Angiogenesis; 2012 Sep; 15(3):497-509. PubMed ID: 22622516 [TBL] [Abstract][Full Text] [Related]
20. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin. Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L Elife; 2020 Apr; 9():. PubMed ID: 32312382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]